Fallopian Tube Adenocarcinoma — Clinical Trials

MONDO:00027463 active·1 recruitingLast updated: Mar 19, 2026, 7:41 PM

Trial Landscape

Fallopian Tube Adenocarcinoma has an emerging clinical trial program, driven by biological therapy and drug treatment.

Recruiting

Active Trials

By Approach

Biological Therapy3

Drug Treatment1

Procedure1

By Phase

Phase 2

Phase 3

Sponsor Types

Industry2NIH1

Top Sponsors

CanariaBio Inc.

MacroGenics

Trial Locations

United States3 trials

Canada2 trials

South Korea2 trials

Argentina1 trial

Belgium1 trial

Brazil1 trial

Chile1 trial

Czechia1 trial

Hungary1 trial

India1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT06730347

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Sponsor:MacroGenics

United StatesStarted: May 2025Est. completion: Aug 2027Updated: Mar 2026

Phase 3Active, Not Recruiting

NCT04498117

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Sponsor:CanariaBio Inc.

United StatesStarted: Aug 2020Est. completion: Aug 2028Updated: Jul 2025

Phase 2Active, Not Recruiting

NCT02834013

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jan 2017Est. completion: May 2026Updated: Mar 2026

Stay informed about clinical trials for Fallopian Tube Adenocarcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 7:41 PM